International Journal of Anthropology

, Volume 21, Issue 1, pp 75–82

Etiology of Developmental Disorders: Good Science, Bad Science, and Pseudoscience

Article

Abstract

Developmental disorders originate in infancy or early childhood, are associated with presumed or observed organic abnormalities, and have serious long-term physical and/or psychological sequelae. Of particular interest here are two such disorders, mental retardation and autism. Purported causes range from genetics, early prenatal and/or postnatal exposure to toxins (including heavy metals), and recently, vaccinations. Single factors have often been claimed to be the cause of a developmental disorder, without regard to possible exacerbating or alleviating roles of other factors, including socioeconomic status. Unfortunately, professional and popular literature on both claimed causes and effective treatments has often been characterized by research and theorizing that is seriously flawed (bad science) or actively misrepresented (pseudoscience). The present paper critically reviews selected research on a few controversial issues concerning developmental disorders, particular mental retardation and autism, and emphasizes the role of low socioeconomic status.

Keywords

Autism Infancy Mental retardation Socioeconomic status 

References

  1. 1.
    Rodier PM (2004) Environmental causes of central nervous system maldevelopment. Pediatrics 113:1076–1083Google Scholar
  2. 2.
    Montagu A (1965) Life before birth. Signet, New YorkGoogle Scholar
  3. 3.
    Lemoine P, Harousseau H, Borteryu JP, Menuet JC (1968) Les enfants de parents alcooliques: anomalies observées à propos de 127 cas. Ouest Medical 21:476–482Google Scholar
  4. 4.
    Jones KL, Smith DW, Ulleland CN, Streissguth AP (1973) Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1:1267–1271CrossRefGoogle Scholar
  5. 5.
    Chernoff GF (1977) The fetal alcohol syndrome in mice: an animal model. Teratology 15:223–230CrossRefGoogle Scholar
  6. 6.
    Farber NB, Olney JW (2003) Drugs of abuse that cause developing neurons to commit suicide. Dev Brain Res 147:37–45CrossRefGoogle Scholar
  7. 7.
    Abel, EL (1998) Fetal alcohol abuse syndrome. Plenum, New YorkGoogle Scholar
  8. 8.
    Stratton K, Howe C, Battaglia FC (eds) (1996) Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. National Academy Press, Washington, DC. Available online: http://www.nap.edu/books/0309052920/html/index.html
  9. 9.
    Sampson PD, Streissguth AP, Bookstein FL, Barr HM (2000) On categorizations in analyses of alcohol teratogenesis. Environ Health Perspect, Suppl 108(#3):421–428Google Scholar
  10. 10.
    Mattson SN, Riley EP (1998) A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res 22:279–294CrossRefGoogle Scholar
  11. 11.
    Jacobson JL, Jacobson SW (1999) Drinking moderately and pregnancy. Alcohol Res Health 23:25–30Google Scholar
  12. 12.
    Burd L, Cotsonas-Hassler TM, Martsolf JT, Kerbeshian J (2003) Recognition and management of fetal alcohol syndrome. Neurotoxicol Teratol 25:681–688CrossRefGoogle Scholar
  13. 13.
    Volkow ND, Li T-K (2005) Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 108:3–17CrossRefGoogle Scholar
  14. 14.
    Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M (1988) Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol 10:497–503CrossRefGoogle Scholar
  15. 15.
    Brown LM, Kim D, Yomai A, Meyer PA, Noonman GP, Huff D, Flanders WD (2005) Blood leads levels and risk factors poisoning in children and caregivers in Chuuk State, Micronesia. Int J Hygiene Environ Health 208:231–236CrossRefGoogle Scholar
  16. 16.
    Needleman HL, Bellinger D (2001) Studies of lead exposure and the developing central nervous system: a reply to Kaufman. Arch Clin Neuropsychol 16:359–374CrossRefGoogle Scholar
  17. 17.
    Smith M, Grant L, Sors A (eds) (1989) Lead Exposure and Child Development: An International Assessment. Kluwer Academic Publishing, Boston, MAGoogle Scholar
  18. 18.
    Warren C (2000) Brush with death: a social history of lead poisoning. Johns Hopkins University Press, Baltimore, MDGoogle Scholar
  19. 19.
    Markowitz GE, Rosner D (2002) Deceit and Denial: The Deadly Politics of Industrial Pollution. University of Berkeley Press, Berkeley, CAGoogle Scholar
  20. 20.
    Kaufman AS (2001) Do low levels of lead produce IQ loss in children? A careful examination of the literature. Arch Clin Neuropsychol 16:303–341CrossRefGoogle Scholar
  21. 21.
    Hebben N (2001) Low lead levels and neuropsychological assessment: let us not be mislead [sic]. Arch Clin Neuropsychol 16:353–357CrossRefGoogle Scholar
  22. 22.
    Brown RT (2001) Behavioral teratology/toxicology: how do we know what we know? Arch Clin Neuropsychol 16:389–402CrossRefGoogle Scholar
  23. 23.
    Nation JR, Gleaves DH (2001) Low-level lead exposure and intelligence in children. Arch Clin Neuropsychol 16:375–388CrossRefGoogle Scholar
  24. 24.
    Wasserman GA, Factor-Litvak P (2001) Methodology, inference and causation: environmental lead exposure and childhood intelligence. Arch Clin Neuropsychol 16:343–352CrossRefGoogle Scholar
  25. 25.
    Chiodo LM, Jacobson SW, Jacobson JL (2004) Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 26:359–371CrossRefGoogle Scholar
  26. 26.
    Kordas K, Canfield RL, López P, Rosado JL, Vargas GG, Cebrián ME, Rico JA, Ronquillo D, Stoltzfus RJ (2006) Deficits in cognitive function and achievement in Mexican first-graders with low blood lead concentrations. Environ Res 100:371-386Google Scholar
  27. 27.
    Bernard S, Enayati A, Redwood L, Roger H, Binstock T (2001) Autism: a novel form of mercury poisoning. Med Hypotheses 56:462–471CrossRefGoogle Scholar
  28. 28.
    Dean C (2005) The politics of mercury poisoning in autism. Total Health 27(1):26–28Google Scholar
  29. 29.
    Giganti J (2004) SafeMinds demonstrates urgency of autism epidemic in new study. Retrieved 20 Nov, 2005 from, http://www.safeminds.org/BlaxillReviewAustismEpidemic.pdf
  30. 30.
    Kennedy R Jr (July 1, 2005) Autism, mercury, and politics. Retrieved 10 Dec., 2005 from, http://www.boston.com/news/globe/editorial_opinion/oped/articles/2005/07/01/autism_mercury_and_politics/
  31. 31.
    Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, Hall AJ (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364:963–969CrossRefGoogle Scholar
  32. 32.
    Frith U, Happé F (2005) Autism spectrum disorder. Curr Biol 15:R786–790CrossRefGoogle Scholar
  33. 33.
    Strock M (2004) Autism Spectrum Disorders (Pervasive Developmental Disorders). NIH Publication No. NIH-04-5511, National Institute of Mental Health, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, 40 pp Retrieved from: http://www.nimh.nih.gov/publicat/autism.cfm
  34. 34.
    Rutter M (2005) Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr 94:2–15CrossRefGoogle Scholar
  35. 35.
    Counter SA, Buchanan LH (2004) Mercury exposure in children: a review. Toxicol Appl Pharmacol 198:209–230CrossRefGoogle Scholar
  36. 36.
    Zahir F, Rizwi SJ, Haq SK, Khan RH (2005) Low dose mercury toxicity and human health. Environ Toxicol Pharmacol 20:351–360CrossRefGoogle Scholar
  37. 37.
    Bernard S, Enayati A, Redwood L, Roger H, Binstock T (2001) Autism: a novel form of mercury poisoning. Med Hypotheses 56:462–471CrossRefGoogle Scholar
  38. 38.
    Geier MR, Geier DA (2003) Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med 228:660–664Google Scholar
  39. 39.
    Geier DA, Geier MR (2005) A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 11:160–170Google Scholar
  40. 40.
    Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793–804CrossRefGoogle Scholar
  41. 41.
    Ball LK, Ball R, Pratt RD (2001) An assessment of thimerosal use in childhood vaccines. Pediatrics 107:1147–1154CrossRefGoogle Scholar
  42. 42.
    Chez MG, Chin K, Hung PC (2004) Immunizations, immunology, and autism. Semin Pediatr Neurol 11:214–217CrossRefGoogle Scholar
  43. 43.
    Clements CJ (2004) The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine 22:1854–1861CrossRefGoogle Scholar
  44. 44.
    DeStefano F, Karapurkar Bhasin T, Thompson WW, Yeargin-Allsopp M, Eiben OG (1998) Growth and maturation problems of children and social inequality during economic liberalization in Central and Eastern Europe. In: Strickland SS, Shetty PS (eds) Human biology and social inequality. Cambridge University Press, Cambridge, UK, pp 76–95Google Scholar
  45. 45.
    Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen, J, Melbye M (2002) A population-based study of measles, mumps, and rubella vaccination and autism. New Engl J Med 347:1477–1482CrossRefGoogle Scholar
  46. 46.
    Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB (2003) Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 112:604–606CrossRefGoogle Scholar
  47. 47.
    Stehr-Green P, Tull P, Stellfeld M, Mortenson P-B, Simpson D (2003) Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med 25:101–106CrossRefGoogle Scholar
  48. 48.
    Blaxill MF, Redwood L, Bernard S (2004) Thimerosal and autism? A plausible hypothesis that should not be dismissed. Med Hypotheses 62:788–794CrossRefGoogle Scholar
  49. 49.
    Eiben OG (1998) Growth and maturation problems of children and social inequality during economic liberalization in Central and Eastern Europe. In: Strickland SS, Shetty PS (eds) Human biology and social inequality. Cambridge University Press, Cambridge, UK, pp 76–95Google Scholar
  50. 50.
    Davidson PW, Myers GJ, Weiss B (2004) Mercury exposure and child development outcomes. Pediatrics 113:1023–1029Google Scholar

Copyright information

© Springer Science + Business Media B.V. 2006

Authors and Affiliations

  1. 1.Psychology DepartmentUniversity of North Carolina WilmingtonWilmingtonUSA

Personalised recommendations